索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李超,彭瑜,张钲.中性粒细胞明胶酶相关脂质运载蛋白与心血管疾病[J].国际心血管病杂志,2017,04:207-209.
点击复制

中性粒细胞明胶酶相关脂质运载蛋白与心血管疾病(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年04期
页码:
207-209
栏目:
综述
出版日期:
2017-07-25

文章信息/Info

Title:
-
作者:
李超; 彭瑜; 张钲
730000 兰州大学第一医院心血管内科
Author(s):
-
关键词:
中性粒细胞明胶酶相关脂质运载蛋白; 标志物; 心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.04.005
文献标识码:
-
摘要:
中性粒细胞明胶酶相关脂质运载蛋白(NGAL)是脂质运载蛋白家族成员。NGAL除了作为急性肾损伤的早期标志物外,可与基质金属蛋白酶9形成复合物,参与血管重构和动脉粥样硬化不稳定性斑块的形成,具有判断心力衰竭和冠状动脉粥样硬化性心脏病患者预后和评估疾病严重程度的能力。
Abstract:
-

参考文献/References

[1] Helanova K, Spinar J, Parenica J. Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin(NGAL)in patients with cardiovascular diseases—review[J]. Kidney Blood Press Res, 2014, 39(6):623-629.
[2] Bao GH, Ho CT, Barasch J. The ligands of neutrophil gelatinase-associated lipocalin[J]. RSC Adv, 2015, 5(126):104363-104374.
[3] Paragas N, Qiu A, Hollmen M, et al. NGAL-Siderocalin in kidney disease[J]. Biochim Biophys Acta, 2012, 1823(9):1451-1458.
[4] Kamble PG, Pereira MJ, Sidibeh CO, et al. Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue[J]. Mol Cell Endocrinol, 2016, 427(C):124-132.
[5] Lv Z, Xu LY, Shen ZY, et al. Overexpression of neutrophil gelatinase-associated lipocalin and its receptor in colorectal carcinoma: significant correlation with cell differentiation and tumour invasion[J]. Oncol Lett, 2010, 1(1):103-108.
[6] Ashraf MI, Schwelberger HG, Brendel KA, et al. Exogenous lipocalin 2 ameliorates acute rejection in a mouse model of renal transplantation[J]. Am J Transplant, 2016, 16(3):808-820.
[7] Cruz DN, Gaiao S, Maisel A, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review[J]. Clin Chem Lab Med, 2012, 50(9):1533-1545.
[8] van der Laan AM, Nahrendorf M, Piek JJ. Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response[J]. Heart, 2012, 98(18):1384-1390.
[9] van der Laan AM, Hirsch A, Robbers LF, et al. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction[J]. Am Heart J, 2012, 163(1):57-65.
[10] Fang L, Moore XL, Dart AM, et al. Systemic inflammatory response following acute myocardial infarction[J]. J Geriatr Cardiol, 2015, 12(3):305-312.
[11] Yndestad A, Landrø L, Ueland T, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure[J]. Eur Heart J, 2009, 30(10):1229-1236.
[12] Soylu K, Aksan G, Nar G, et al. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome[J]. Anatol J Cardiol, 2015, 15(6):450-455.
[13] Katagiri M, Takahashi M, Doi K, et al. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease[J]. Heart Vessels, 2016, 31(10):1595-1602.
[14] Sahinarslan A, Kocaman SA, Bas D, et al. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease[J]. Coron Artery Dis, 2011, 22(5):333-338.
[15] Cheng JM, Akkerhuis KM, Meilhac O, et al. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography[J]. Arterioscler Thromb Vasc Biol, 2014, 34(5):1078-1084.
[16] Lindberg S, Pedersen SH, Mogelvang R, et al. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention[J]. J Am Coll Cardiol, 2012, 60(4):339-345.
[17] Helanova K, Littnerova S, Kubena P, et al. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study[J]. BMJ Open, 2015, 5(10):e006872.
[18] Kirbi S, Gorenjak M, Sinkovicˇ A. The role of urine neutrophil gelatinase-associated lipocalin(NGAL)in acute heart failure in patients with ST-elevation myocardial infarction[J]. BMC Cardiovasc Disord, 2015, 15:49.
[19] Tawfeek MS, Raafat DM, Saad K, et al. Plasma levels of neutrophil gelatinase-associated lipocalin in children with heart failure[J]. Ther Adv Cardiovasc Dis, 2016, 10(1):30-36.
[20] van Deursen VM, Damman K, Voors AA, et al. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure[J]. Circ Heart Fail, 2014, 7(1):35-42.
[21] Nymo SH, Ueland T, Askevold ET, et al. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA[J]. J Intern Med, 2012, 271(5):436-443.

备注/Memo

备注/Memo:
基金项目:国家重点临床科室项目(2013); 甘肃省重点实验室项目(2012)
通信作者:张 钲,Email:zhangccu@163.com
更新日期/Last Update: 2017-07-25